Oxidized low-density lipoprotein (oxLDL) in diabetic patients enhances monocyte chemoattractant protein-1 (MCP1) gene expression in endothelial cells, increasing the atherogenic process and promoting endothelial dysfunction [53]. Here, CCL2 is linked to endothelial dysfunction.